Alessandro Laganà

12PUBLICATIONS
10CO-AUTHORS
Molecular targetsRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 26, 2026
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission.

|Oct 16, 2025
Increased Rate of Anemia and Discontinuation in Older Patients with Myelofibrosis Treated with Ruxolitinib.

Alessandro Laganà, Emilia Scalzulli, Ida Carmosino

|Jun 30, 2025
Treatment Free Remission (TFR) in Chronic Phase-Chronic Myeloid Leukemia (CP-CML): Analysis of Predictive Factors and Novel Baseline Scoring System to Predict Molecular Relapse.

Alessandro Laganà, Emilia Scalzulli, Ida Carmosino

|Apr 28, 2025
CD99 expression in acute myeloid leukemia with FLT3 internal tandem duplications (FLT3-ITDmut-AML): a flow-cytometric marker for an accurate diagnostic workup.

Alessandro Laganà, Deborah Kasmi, Daniela Diverio

|Jan 17, 2025
Red Blood Cell Distribution Width May Predict Drug-Induced Anemia and Prognosis in Patients Affected by Primary/Secondary Myelofibrosis Treated with Ruxolitinib.

Alessandro Laganà, Emilia Scalzulli, Ida Carmosino

|Dec 08, 2024
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in Chronic myeloid leukemia (CML).

Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna

Pageof 2

Frequent Collaborators

10 joint publications

Massimo Breccia

4 joint publications

Claudia Ielo

2 joint publications

Alessandro Costa

1 joint publications

Chiara Masucci